NOVATO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. today announced that Jeffrey H. Cooper, Senior Vice President and Chief Financial Officer of BioMarin, will present a company update at the Thomas Weisel Partners Healthcare Conference in Boston on Thursday, September 10, 2009 at 4:25 p.m. ET.
About BioMarin
BioMarin(R), Naglazyme(R) and Kuvan(R) are registered trademarks of BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
